Mosquitoes are the carriers of severe and well-known illnesses such as malaria, arboviral encephalitis, dengue, chikungunya and yellow fever, which cause significant morbidity and mortality in humans and domestic animals around the world. Entomopathogenic fungal metabolites act as a mosquito control agent and are potential alternatives to chemical control because they can be innovative and more selective than chemical insecticides. The main aim of the present study was to perform experiments on the larvicidal and pupicidal effects of the entomopathogenic fungus Beauveria bassiana (isolated from infected grasshopper) against the first to fourth instar larvae of Anopheles stephensi, Culex quinquefasciatus and Aedes aegypti. The larval and pupal mortality were observed after 24 h of exposure. ). Based on Fourier transform infrared spectroscopy (FTIR) analysis and gas chromatography-mass spectrometry (GC-MS)
Introduction
Vector-borne diseases are illnesses caused by pathogens and parasites in human populations. Globally, every year there are about more than 1 billion cases and over 1 million deaths due to vector-borne diseases, such as malaria, dengue, schistosomiasis, human African trypanosomiasis, leishmaniasis, chagas disease, yellow fever, Japanese encephalitis and onchocerciasis. Vectorborne diseases account for over 17% of all infectious diseases. Malaria is a parasitic disease spread by infected Anopheles mosquitoes, which is caused by parasite species namely Plasmodium falciparum, P. vivax, P. malariae and P. ovale. 1 Malaria causes symptoms that typically include fever and headache, which in severe cases can lead to coma or death. A recent survey released in December 2014 reported about 198 million cases of malaria in 2013 with an uncertainty range from 124 million to 283 million and an estimated 584000 deaths (with an uncertainty range of 367 000 to 755 000). Malarial mortality rates have fallen globally by 47% since 2000 and 54% reported in the African regions.
Culex mosquitoes are painful and persistent biters and are responsible for lariasis. Lymphatic lariasis is a neglected tropical disease. Lymphatic lariasis is commonly known as elephantiasis and infection occurs when larial parasites are transmitted to humans through mosquitoes.
3 When a mosquito with infective stage larvae bites a person, the parasites are deposited on the person's skin from where they enter into the body. The larvae then migrate to the lymphatic vessels where they develop into adult worms in the lymphatic system. Worldwide, more than 1.3 billion people from 72 countries are threatened by lymphatic lariasis, commonly known as elephantiasis. 4 Chikungunya is a viral tropical disease transmitted by Aedes mosquitoes. The disease is prevalent in Africa, Asia, the islands in the Caribbean, India and Pacic oceans. Typical symptoms are an acute illness with fever, skin rash and incapacitating joint pain that can last for weeks. 5 The latter distinguishes chikungunya virus from dengue, which otherwise shares the same vectors, symptoms and geographical distribution. There is no cure or commercial vaccine for the disease. Most patients recover fully; however, in some cases, joint pain may persist for several months or even years. As with dengue, the only method to reduce the transmission of the chikungunya virus is to control vector mosquitoes and protect against mosquito bites. Yellow fever is an acute viral hemorrhagic disease transmitted by Aedes mosquitoes. The "yellow" in the name refers to the jaundice that affects some patients. There are an estimated 200 000 cases of yellow fever, which cause 30 000 deaths worldwide per year. The virus that causes yellow fever is endemic in densely populated countries, viz., Tropical Africa and Latin America. Small numbers of imported cases occur in countries free of yellow fever.
6
The common control agents for mosquito larvicides are mainly dependent on chemical methods using synthetic insecticides that are likely to include, organophosphates such as temephos, fenthion, phytochemicals and insect growth regulators such as diubenzuron, and methoprene. 7 However, most of these synthetics have adverse effects on the environment. Due to their residual nature there are reports on the development of pesticide resistance in mosquitoes 8 rendering them ineffective for further applications. These problems encourage the search for safer and better alternative bioactive larvicidal agents. Although various biocontrol measures are in vogue, to date, their effective control of larval mosquitoes has not been practically highlighted. Microbial control is recommended as an alternative way, and microbial based larvicides are employed for minimizing the mosquito population, which provides an effective, environmentally friendly and sociable approach to bring the mosquito population to the lowest level.
9,10
Beauveria bassiana (Clavicipitaceae) is a soil borne fungus that feeds on insects and can be used effectively to control thrips, aphids, whitey, caterpillars, beetles, and subterranean insects like ants and termites. B. bassiana is non-toxic to mammals, birds and plants, and its use is not expected to have any deleterious effects on human health or the environment.
11
Conidia of B. bassiana has been reported to be effective in killing mosquito larvae when applied as conidia dust in the breeding sites. Besides infecting larvae, the fungus has also proven to be virulent to adult mosquitoes.
12 B. bassiana is applied to the target pest as a spore, which is the reproductive and dispersal structure of the fungus. Once the spores have made contact with the insect exoskeleton, they grow hyphae (long, branching vegetative appendages) that secrete enzymes, which in turn dissolve the cuticle (outermost layer of the skeleton). These fungal hyphae grow into the insect, feed on its body tissue, produce toxins, and reproduce. It takes up to seven days for the insect to die. During favorable (moist) conditions (92% humidity or greater), B. bassiana will "bloom" and release more spores into the environment to repeat the cycle on other pest insects. 13 The species of Beauveria has been reported to produce secondary metabolites, including bassianin, bassiacridin, beauvericin, bassianolide, beauverolides, tenellin and oosporein.
14-16 It also produces proteases, chitinases and lipases, which can degrade the insect cuticle. 17 In this regard, the entomopathogenic fungi, viz., Aspergillus avus, A. parasiticus, Penicillium falicum, Fusarium vasinfectum and Trichoderma viride and soil bacteria, Bacillus thuringiensis and B. sphaericus have been reported to be effective against Cx. quinquefasciatus.
18
Hence, the present study was focused on the insecticidal potential of Beauveria bassiana mycelial extracts against target mosquitoes.
Materials and methods

Isolation and identication of entomopathogenic fungus
The entomopathogenic fungus B. bassiana was isolated from an infected grasshopper (Melanoplus sanguinipes) collected from an agricultural eld (latitude 11.6500 N, longitude 78.1600 E) in the Salem District, Tamilnadu, India. The cadaver was placed on potato dextrose agar (PDA (Hi-Media)) supplemented with streptomycin (1 mg/100 mL) and incubated for 7 days at 27 C AE 2 C. 19 Aer 7 days of incubation, the pure culture of B. bassiana was subcultured into PDA using the streak plate method. The isolated culture was identied using the slide culture method subjected to lactophenol cotton blue staining and observed under a light microscope (Labomed). Mycotaxonomic keys followed by Samson 20 and Samson et al. 21 were used to identify the fungus.
Morphological identication of B. bassiana
The fungus was primarily identied based on its morphological features, descriptions of species, keys to taxa and additional information from ''Studies in Mycology''. 22 Colonies of B. bassiana fungus were cultivated on Sabouraud's dextrose agar at 25 C for 7 days. The following morphological characteristics were assessed: colony growth (length and width), the presence or absence of aerial mycelium, colony color, presence of wrinkles, furrows and pigment production.
in Sabouraud's Dextrose Broth (SDB). Ten 250 mL conical asks, each containing 100 mL of SDB (dextrose 40 g, peptone 10 g, deionized water 1000 mL), autoclaved at 20 psi for 20 min. The broths were supplemented with 50 mg mL À1 chloramphenicol, which acted as a bacteriostatic agent. The B. bassiana colonies grown on the Sabouraud's dextrose agar plates were transferred to each ask (using an inoculation needle). The conical asks inoculated with B. bassiana were incubated at 25 C for 25 days.
Secondary metabolite extraction from B. bassiana
Mass cultivation of the fungus was carried out in a 250 mL Erlenmeyer ask containing 100 mL of Sabouraud's dextrose broth medium. The culture asks were incubated under the optimized culture conditions (pH 7.0, temperature 27 C) for 25 days. For the liquid culture, the fungal mycelium mat was washed three times with sterile distilled water to remove adherent ltrate and subjected to an extraction of biologically active components using ethyl acetate and methanol solvents. The solvents were mixed to the mycelia mat for cold extraction for 7 days at room temperature. Aer thorough mixing, the immiscible portion of ethyl acetate (pale yellow colored) was separated from the mycelium. Tamilnadu, India. The larvae were kept in plastic enamel trays containing dechlorinated tap water. They were maintained as per the previous report of Patil et al. 25 The larvae were fed on dog biscuits and yeast powder in 3 : 1 ratio. Adults were fed with blood through a paraffin membrane and provided with 10% sucrose solution. Mosquitoes were kept at 28 C AE 2 C and 70-85% relative humidity with a photoperiod of 12 h light/12 h dark.
Larvicidal bioassay
The larval mortality bioassays were carried out according to the method suggested by the World Health Organization 26 with slight modications. 27 Sufficient amounts of ethyl acetate and methanol extracts were transferred to a vial, and the residual solvent was removed under high vacuum. Stock solutions of each test mycelium extract in dimethyl sulfoxide (DMSO) were prepared with a concentration of 10% w/v (1 mg of extracts in 1000 mL of DMSO) prepared into ve different concentrations viz. 50, 100, 150, 250 and 300 mg mL À1 with distilled water at pH 7.0. Twenty numbers of late rst to early fourth-instar mosquito larvae were placed in a 2% v/v aqueous solution of DMSO (99 mL of distilled water plus 1 mL of DMSO), followed by the addition of the test solutions. Five replicates per dose were maintained, and a treatment with 99 mL of tap water and 1 mL of DMSO was added to each bioassay as the control at pH 7.0. During this experiment, no food was provided to the larvae. The larval mortality was calculated aer 24 h of exposure.
Corrected mortality ¼ observed mortality in treatment À observed mortality in control 100 À control mortality Â 100
Pupal toxicity tests
The laboratory colony of mosquito pupae was used to test the pupicidal activity of the B. bassiana extracts. Twenty freshly emerged pupae were kept in a 100 mL glass beaker containing 99 mL of dechlorinated water and a different concentrations of mycelium extracts (50, 100, 150, 200, 250 and 300 mg mL À1 ). The experiment consists of ve replicates; the control containing 1 mL of DMSO in 99 mL of dechlorinated water at pH 7.0. The mortality in the treatments and control was corrected using Abbott's formula. 28 The LC 50 and LC 90 were calculated from toxicity data using probit analysis.
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Percentage of mortality ¼ number of dead larvae=pupae number of larvae=pupae introduced Â 100
Dose response bioassay
The stock solutions obtained from the mycelia extract at different concentrations (ranging from 50 to 300 mg mL À1 ) were prepared as per the method of Rahuman et al. 30 Based on the preliminary screening results, the mycelium extracts of B. bassiana were subjected to a dose-response bioassay for larvicidal and pupicidal activity against rst to fourth instar larvae and pupae of An. stephensi, Cx. quinquefasciatus and Ae. aegypti. The number of dead larvae were counted aer 24 h of exposure, and the percentage mortality was reported from the average of ve replicates.
Preparation of the standard n-Hexadecanoic acid was procured from Sigma, USA and DMSO was used as the solvent to prepare the stock solution. The stock solution was diluted further to produce the required concentrations to perform the bioassay tests.
31
Control experiment (Acremonium sp. non-pathogenic fungi)
The larval and pupal mortality bioassays of Acremonium sp. were carried out according to the method suggested by the World Health Organization with slight modications.
26,27 A sufficient amount of the Acremonium sp. ethyl acetate extracts was transferred to a vial, and the residual solvent was removed under high vacuum. The stock solution of Acremonium mycelial ethyl acetate extract was prepared using dimethyl sulfoxide (DMSO) with a concentration of 10% w/v (1 mg of extracts in 1000 mL of DMSO). Then, it was diluted into ve different concentrations, viz., 50, 100, 150, 250 and 300 mg mL À1 , and used for bioassay. 
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Fourier transformed infrared spectroscopy (FTIR)
1.0 mg of sample was mixed with 100 mg of KBr (binding agent) using a clean mortar and a pestle to produce a powder. The powder was made into pellets using a hydraulic press. The pellets were then subjected to FTIR analysis on a BRUKER a-T FTIR spectrometer. The precision of the FTIR spectra was better than 0.09 cm À1 and the scanning range was from 4000 to 500 cm À1 . 32 FTIR analysis was carried out in the Department of Physics, Periyar University, Salem, Tamilnadu, India.
Gas chromatography-mass spectrophotometry (GC-MS) analysis
GC-MS analysis of the samples was carried out on a Perkin Elmer (clarus 680) series GC-MS (Marathon, USA) system equipped with clarus 600 (EI) auto-sampler coupled with an Elite-5 MS capillary column (30 m Â 0.25 mm i.d., and 0.250 mm) (PerkinElmer, Inc, made in USA). Helium was used as the carrier gas at a ow rate of 1 mL min À1 ; split ratio of 10 : 1; mass scan 50-600 Da; ionization energy, 70 eV; ion source temperature, 240 C; injector temperature, 250 C. The oven temperature was programmed as follows: initially at 60 C for 2 min, rising at 10 C min À1 to 300 C and then held isothermally (6 min) at 300 C with a total run time of 32 min. The percentage composition of the crude extract constituents was expressed as a percentage of the peak area. The chemical compounds were identied and characterized based on their retention time (RT). The obtained mass spectral data (GC-MS) was matched with those of standards available in the existing computer library (NIST) data base. 33 The GC-MS analysis was carried out in the Sophisticated Instrument Facility, (SAIF). Vellore Institute of Technology (VIT), Vellore, Tamilnadu, India.
High performance liquid chromatography (HPLC) analysis
The B. bassiana mycelium ethyl acetate extract and pure n-hexadecanoic acid were diluted and subjected to high performance liquid chromatography (HPLC) analysis. For the chromatographic analysis of ethyl acetate extract and pure n-hexadecanoic acid, the samples were detected using an LC-20AD HPLC system (Shimadzu Chromatographic Instruments, Japan) equipped with a C18 reverse phase column (particle size: 5 mm; length: 4.6 Â 250 mm) and a SPD-20A UV/Vis detector at 242 nm absorbance with methanol : water (50 : 50) at a ow rate of 1 mL min À1 and head pressure of 300 kgf cm À2 . The entire instrument room setup was maintained at room temperature (23 C) following the method of Junaid Khan et al. 34 n-Hexadecanoic acid was used as the standard. The amount of specic compounds that resembles the standard was expressed as micrograms per gram.
Statistical analysis
The percentage of larval mortality was calculated using the Abbott formula. 28 The dose-response data were subjected to probit regression analysis 29 for calculating the LC 50 , LC 90 , 95% ducial limits of upper condence limit and lower condence limit, and the chi-square values were calculated using the IBM SPSS (Statistical Package of Social Sciences) soware version 20.0 developed by Reddy et al. 35 Results with P < 0.05 were considered to be statistically signicant.
Results
The fungal strain was isolated from an infected grasshopper, Melanoplus sanguinipes. The SDA plates showed (aer incubation) a fungus with white uffy cottony growth with pale yellow edges. The piece of mycelium was stained with lactophenol cotton blue and observed under a microscope (Lobomed, 40Â) showing abundant conidiospores arising from the vegetative hyphae, bearing groups of clustered conidiogenous cells with the apical zig-zag appearance, branched to give rise to further conidiogenous cells; globose to ask-shaped, one-celled spherical conidia were recorded. Previously Hermanides 36 and Seyed Ali Safari 37 identied B. bassiana using fungal key manual 'Studies in Mycology'.
The larvicidal activity of mycelium ethyl acetate and methanol extracts obtained from B. bassiana was investigated. The ethyl acetate mycelium extract had a promising larvicidal activity ( from B. bassiana, the mortality rates were slower, but the larvae became very slow-moving when compared with the control. The sub-lethal effects on the rst and second larval instars were correlated with the minimum survival of the third and fourth instar larvae. The third and fourth instars larvae were also susceptible in the bioassay at the lowest lethal concentration. The dose dependent assay results showed that maximum (100%) mortality was obtained at a higher concentration (300 mg mL À1 ) against the different stages of instar larvae of the An.
stephensi, Cx. quinquefasciatus and Ae. aegypti mosquitoes. At a higher concentration of extracts, the mortality rate was exhibited within 5 h of exposure. More than 50% mortality was observed within the rst 10 h. The control showed a nil mortality in the concurrent assay. The c 2 value was signicant at the P < 0.05 level.
The results of the pupal mortality of mosquitoes ( of the mortality was observed within 18 h for An. stephensi and Cx. quinquefasciatus, followed by Ae. Aegypti, and a 100% pupal mortality was observed at the higher concentration of the extracts. The pupal toxicity revealed a dose-dependent mortality in the treatment against the An. stephensi, Cx. quinquefasciatus and Ae. aegypti. Based on the results, the ethyl acetate extract obtained from the fungal species was found to be an excellent pupicidal agent against the targeted mosquitoes An. stephensi, Cx. quinquefasciatus and Ae. aegypti. In addition, the toxicity of the n-hexadecanoic acid standard was tested against An. stephensi, Cx. quinquefasciatus and Ae. aegypti. The LC 50 values of n-hexadecanoic acid against the rst, second, third and fourth instar larvae of An. stephensi (LC 50 obtained from the present study. FTIR spectroscopy was used to identify the functional groups of the active compounds based on the peak value in the infrared region. FTIR analysis of the ethyl acetate mycelium extract showed the presence of prominent bands due to the O-H group of hydrogen-bonded alcohols or phenols (3420. Fig. 2 and Table 5 ). The GC-MS results obtained from the ethyl acetate extract of B. bassiana indicated the presence of six major compounds viz. 9,12-octadecadienoic acid (ZZ)-(63.16%), n-hexadecanoic acid (21.28%), octadecanoic acid, phenyl methyl ester (10.45%), dehydroegosterol 3,5-dinitrobenzoate (1.86%), squalene (1.66%), and bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)prophyl] maleate (1.56%) (Fig. 3 and Table 6 ). Hence, the isolated bioactive compounds obtained from the B. bassiana derived products, with proven potential as an insecticide, can play an important role in the interruption of the transmission of mosquito-borne diseases. The larvicidal and pupicidal activity of the ethyl acetate extract may be due to the presence of major bioinsecticide constituents such as 9,12-octadecadienoic acid (ZZ)-and n-hexadecanoic acid.
HPLC analysis of the ethyl acetate mycelium extract of B. bassiana and the n-hexadecanoic acid standard showed a similar chromatographic peak (at the retention time 3.383 and 3.378 min) (Fig. 4a and b) .
Discussion
Microbial sources serve as a guide for the isolation of several bioactive compounds particularly mosquito control agents. The entomopathogenic fungi have the ability to directly infect the 50 -lethal concentration that kills 50% of the exposed larvae, LC 90 -lethal concentration that kills 90% of the exposed larvae, LCL ¼ lower condence limit, UCL ¼ upper condence limit, df degree of freedom, * c 2 -chi-square values are signicant at P < 0.05 levels.
b The mean value of ve replicates (AESE). 14 The results of fungal identication showed conidiogenous cells of B. bassiana densely clustered in whorls, globose or ask-like base, hyaline, smooth and short. The new conidium, giving a distinct zig-zag appearance in its colonies on PDA were round and at, like a hyaline lm from the radial growing mycelium. Similar results from B. bassiana were reported by Draganova et al. 38 B. bassiana (Balsamo) is considered a very important and promising fungal agent for use in the control of insects. 39 The fungus causes high mortalities in mosquito populations, as tested in numerous laboratories; Neetu Vyas et al. 40 reported that Lagenidium giganteum fungus metabolites showed 100% mortality in rst instar larvae against An. stephensi, Ae. aegypti, and Cx. quinquefasciatus. Mohanty and Prakash 41 have described that the ltrate metabolites of Trichophyton ajelloi are effective on the larvae of two mosquito species, Cx. quinquefasciatus and An. stephensi. The culture ltrate metabolites of Chrysosporium tropicum were also found to be toxic and showed an LC 50 and LC 90 toxicity for all larval instars of An. stephensi tested at different concentrations. a Control (deionized water) -nil mortality. LC 50 -lethal concentration that kills 50% of the exposed larvae, LC 90 -lethal concentration that kills 90% of the exposed larvae, LCL ¼ lower condence limit, UCL ¼ upper condence limit, df degree of freedom, c 2 -chi-square values are signicant at P < 0.05 levels.
b The mean value of ve replicates (AESE). 50 -lethal concentration that kills 50% of the exposed larvae, LC 90 -lethal concentration that kills 90% of the exposed larvae, LCL ¼ lower condence limit, UCL ¼ upper condence limit, df degree of freedom, * c 2 -chi-square values are signicant at P < 0.05 levels.
b The mean value of ve replicates (AESE).
The present study exhibited that the bioactive metabolites of B. bassiana have larvicidal and pupicidal activity against Anopheles, Culex and Aedes mosquitoes. These metabolites may destroy the cuticle layer of the larvae and pupae, which leads to the death of the larvae and pupa. A similar study has been reported by Ababutain et al., 42 which identied Streptomyces sp. having better mosquitocidal properties. The use of fungus and their products are virulent and are a promising alternative insecticidal control agent. 43 The efficacy of the insecticidal activity of B. bassiana products against the larvae of An. stephensi, Cx. quinquefasciatus and Ae. aegypti larvae showed that the LC 50 50 and LC 90 values were reported as follows: the LC 50 value of I instar was 9.332%, II instar was 9.832%, III instar was 10.212%, and IV instar was 10.622%, whereas the LC 90 value of I instar was 15.225%, II instar was 15.508%, III instar was 15.887% and IV instar was 15.986%. Similar studies have been carried out by several researchers using bacteria Bacillus thuringiensis, 45, 46 Bacillus sphaericus 47 and fungus Trichoderma viride 48 and Actinobacteria, 49 entomopathogenic fungi Metarhizium, 50 Trichophyton, 41 Tolypocladium, 51 Chrysosporium 52 and Lagenidium 53 were reported as potential insecticidal agents.
The outcome of present study proved that mycelium extract of B. bassiana had a broad spectrum larval mortality against An. stephensi, Cx. quinquefasciatus and Ae. aegypti and the values were found to be as follows: for An. stephensi, LC 50 . The larval and pupal mortality of Cx. quinquefasciatus aer 24 h of treatment with the n-hexadecanoic acid standard 50 -lethal concentration that kills 50% of the exposed larvae, LC 90 -lethal concentration that kills 90% of the exposed larvae, LCL ¼ lower condence limit, UCL ¼ upper condence limit, df degree of freedom, c 2 -chi-square values are signicant at P < 0.05 levels.
b The mean value of ve replicates (AESE). 59 The GC-MS analysis results revealed that the larvicidal and pupicidal activity of mycelium ethyl acetate extracts from B. bassiana were exhibited due to six major compounds, namely 9,12-octadecadienoic acid (ZZ)-(63.16%), n-hexadecanoic acid (21.28%), octadecanoic acid, phenyl methyl ester (10.45%), dehydroegosterol 3,5-dinitrobenzoate (1.86%), squalene (1.66%), bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)prophyl]maleate (1.56%). Earlier, Ragavendran and Natarajan 60 reported that the Aspergillus terreus ethyl acetate extract contains six bioactive compounds and its constituents The HPLC analysis of the ethyl acetate mycelium extract was compared with the n-hexadecanoic acid standard and they showed a similar chromatographic peak (at a retention time of 3.383 and 3.378 min). The HPLC results were in agreement with the earlier reports of Ragavendran and Natarajan, 60 and Manilal et al. 68 who obtained (15.31 and 42%) n-hexadeconoic acid using different extracts. Previously, several researchers have isolated n-hexadecanoic acid from different plants and microbes i.e. Vitex altissima, V. negundo and V. trifolia, 69 Aspergillus fumigatus, 70 A. versicolor 71 and Pestalotiopsis sp. 72 The use of fungus Fig. 3 The insecticidal compounds identified in the ethyl acetate mycelium extracts obtained from B. bassiana. based products would be cheaper, target-specic, self-sustained and highly toxic to mosquitoes, even at low doses.
Conclusion
Our ndings conrm a promising as well as a novel biological based strategy to be integrated with additional control measures to reduce the global rate of vector-borne disease transmission. At a concentration of 300 mg mL À1 of B. bassiana ethyl acetate extract, 90% mortality was observed within 18 h against An. stephensi and Cx. quinquefasciatus, followed by Ae. aegypti and 100% pupal mortality was observed at higher concentrations. The pupal toxicity of the mosquitoes was mainly based on the dose-dependent effect against An. stephensi, Cx. quinquefasciatus and Ae. aegypti. GC-MS analysis of the ethyl acetate extract of B. bassiana identied six major components, i.e. 9,12-octadecadienoic acid (ZZ)-(63.16%), n-hexadecanoic acid (21.28%), octadecanoic acid, phenyl methyl ester (10.45%), dehydroegosterol 3,5-dinitrobenzoate (1.86%), squalene (1.66%) and bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl) prophyl]maleate (1.56%). The bioactive compounds may be responsible for the larvicidal and pupicidal activity against An. stephensi, Cx. quinquefasciatus and Ae. aegypti mosquitoes. In addition, HPLC analysis of the ethyl acetate mycelium extract of B. bassiana and the n-hexadecanoic acid standard show a similar chromatographic peak (at a retention time of 3.383 and 3.378 min). Moreover, these metabolites can be used for the development of new insecticidal formulations to control vector borne diseases because they constitute a rich source of bioactive compounds that are more effective, eco-friendly, non-toxic, and potentially suitable for use in the management of target insects/pests. Further studies are ongoing for the isolation of pure active compounds and determination of the mode of action so as to recommend an ecofriendly measure for the control of mosquitoes.
